Clinical Trial Update: A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO) [Phase 3]

View source ↗

Summary

A 12-month, Phase 3 open-label study evaluated the long-term safety of Vimovo (naproxen/esomeprazole) for gastric ulcer; the trial has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Vimovo (naproxen/esomeprazole) (naproxen/esomeprazole)

Snippet

Sponsor: POZEN | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2010-08-20